Research statistics

PACAP-38 research: publications and trials

What has been published on PACAP-38: PubMed publications, the kind of evidence they report and registered clinical trials. These are counts of research, not a judgment of whether PACAP-38 works or is safe. For what it is and what the studies found, see the PACAP-38 profile.
Automated weekly refresh · data through November 8, 2026

At a glance

Publications, all years

3,881

Since 1989

Publications in 2026 so far

61

Through November 8, 2026

Human clinical research

4.5%

174 of 3,836 classified

Registered clinical trials

13

ClinicalTrials.gov

Randomized controlled trials

31

Publications reporting an RCT in people

Systematic reviews and meta-analyses

5

Preclinical studies

81.2%

2,613 animal · 487 in vitro · 14 computational

Records that only mention it

690

Not counted above

Status in the library: Research only. Groups: Cognitive and neurological peptides. 45 publications are not yet classified by study type.

What to keep in mind

  • More than 70% of the indexed publications are animal, cell or computational studies.
  • Some completed trials have neither posted results nor a linked results publication.
  • The body makes this molecule itself, so much of its literature is physiology rather than research on it as a compound.

Publications by year

PACAP-38 publications by year and evidence

1989, Preclinical (animal, in vitro, computational): 1 of 11990, Preclinical (animal, in vitro, computational): 12 of 131990, Other and not yet classified: 1 of 131991, Preclinical (animal, in vitro, computational): 26 of 291991, Reviews and meta-analyses: 1 of 291991, Other and not yet classified: 2 of 291992, Human clinical research: 2 of 541992, Preclinical (animal, in vitro, computational): 47 of 541992, Reviews and meta-analyses: 3 of 541992, Other and not yet classified: 2 of 541993, Human clinical research: 1 of 761993, Preclinical (animal, in vitro, computational): 71 of 761993, Reviews and meta-analyses: 2 of 761993, Other and not yet classified: 2 of 761994, Human clinical research: 1 of 971994, Preclinical (animal, in vitro, computational): 87 of 971994, Reviews and meta-analyses: 8 of 971994, Other and not yet classified: 1 of 971995, Human clinical research: 3 of 1161995, Preclinical (animal, in vitro, computational): 105 of 1161995, Reviews and meta-analyses: 3 of 1161995, Other and not yet classified: 5 of 1161996, Human clinical research: 1 of 1871996, Preclinical (animal, in vitro, computational): 153 of 1871996, Reviews and meta-analyses: 23 of 1871996, Other and not yet classified: 10 of 1871997, Human clinical research: 3 of 1401997, Preclinical (animal, in vitro, computational): 127 of 1401997, Reviews and meta-analyses: 7 of 1401997, Other and not yet classified: 3 of 1401998, Human clinical research: 3 of 2011998, Preclinical (animal, in vitro, computational): 173 of 2011998, Reviews and meta-analyses: 18 of 2011998, Other and not yet classified: 7 of 2011999, Human clinical research: 1 of 1301999, Preclinical (animal, in vitro, computational): 116 of 1301999, Reviews and meta-analyses: 9 of 1301999, Other and not yet classified: 4 of 1302000, Human clinical research: 1 of 1782000, Preclinical (animal, in vitro, computational): 167 of 1782000, Reviews and meta-analyses: 8 of 1782000, Other and not yet classified: 2 of 1782001, Human clinical research: 2 of 1462001, Preclinical (animal, in vitro, computational): 136 of 1462001, Reviews and meta-analyses: 8 of 1462002, Human clinical research: 1 of 1582002, Preclinical (animal, in vitro, computational): 135 of 1582002, Reviews and meta-analyses: 19 of 1582002, Other and not yet classified: 3 of 1582003, Human clinical research: 2 of 1232003, Preclinical (animal, in vitro, computational): 106 of 1232003, Reviews and meta-analyses: 14 of 1232003, Other and not yet classified: 1 of 1232004, Human clinical research: 2 of 1282004, Preclinical (animal, in vitro, computational): 106 of 1282004, Reviews and meta-analyses: 17 of 1282004, Other and not yet classified: 3 of 1282005, Human clinical research: 1 of 992005, Preclinical (animal, in vitro, computational): 85 of 992005, Reviews and meta-analyses: 10 of 992005, Other and not yet classified: 3 of 992006, Human clinical research: 6 of 1702006, Preclinical (animal, in vitro, computational): 142 of 1702006, Reviews and meta-analyses: 16 of 1702006, Other and not yet classified: 6 of 1702007, Human clinical research: 6 of 1262007, Preclinical (animal, in vitro, computational): 87 of 1262007, Reviews and meta-analyses: 30 of 1262007, Other and not yet classified: 3 of 1262008, Human clinical research: 4 of 1182008, Preclinical (animal, in vitro, computational): 97 of 1182008, Reviews and meta-analyses: 14 of 1182008, Other and not yet classified: 3 of 1182009, Human clinical research: 3 of 902009, Preclinical (animal, in vitro, computational): 77 of 902009, Reviews and meta-analyses: 10 of 902010, Human clinical research: 8 of 1332010, Preclinical (animal, in vitro, computational): 110 of 1332010, Reviews and meta-analyses: 12 of 1332010, Other and not yet classified: 3 of 1332011, Human clinical research: 5 of 812011, Preclinical (animal, in vitro, computational): 59 of 812011, Reviews and meta-analyses: 15 of 812011, Other and not yet classified: 2 of 812012, Human clinical research: 5 of 952012, Preclinical (animal, in vitro, computational): 79 of 952012, Reviews and meta-analyses: 10 of 952012, Other and not yet classified: 1 of 952013, Human clinical research: 6 of 982013, Preclinical (animal, in vitro, computational): 72 of 982013, Reviews and meta-analyses: 16 of 982013, Other and not yet classified: 4 of 982014, Human clinical research: 7 of 1032014, Preclinical (animal, in vitro, computational): 87 of 1032014, Reviews and meta-analyses: 6 of 1032014, Other and not yet classified: 3 of 1032015, Human clinical research: 7 of 862015, Preclinical (animal, in vitro, computational): 66 of 862015, Reviews and meta-analyses: 11 of 862015, Other and not yet classified: 2 of 862016, Human clinical research: 14 of 872016, Preclinical (animal, in vitro, computational): 62 of 872016, Reviews and meta-analyses: 9 of 872016, Other and not yet classified: 2 of 872017, Human clinical research: 2 of 672017, Preclinical (animal, in vitro, computational): 51 of 672017, Reviews and meta-analyses: 11 of 672017, Other and not yet classified: 3 of 672018, Human clinical research: 3 of 942018, Preclinical (animal, in vitro, computational): 62 of 942018, Reviews and meta-analyses: 28 of 942018, Other and not yet classified: 1 of 942019, Human clinical research: 8 of 892019, Preclinical (animal, in vitro, computational): 60 of 892019, Reviews and meta-analyses: 19 of 892019, Other and not yet classified: 2 of 892020, Human clinical research: 10 of 822020, Preclinical (animal, in vitro, computational): 52 of 822020, Reviews and meta-analyses: 18 of 822020, Other and not yet classified: 2 of 822021, Human clinical research: 11 of 972021, Preclinical (animal, in vitro, computational): 57 of 972021, Reviews and meta-analyses: 25 of 972021, Other and not yet classified: 4 of 972022, Human clinical research: 8 of 852022, Preclinical (animal, in vitro, computational): 55 of 852022, Reviews and meta-analyses: 18 of 852022, Other and not yet classified: 4 of 852023, Human clinical research: 11 of 952023, Preclinical (animal, in vitro, computational): 60 of 952023, Reviews and meta-analyses: 23 of 952023, Other and not yet classified: 1 of 952024, Human clinical research: 10 of 692024, Preclinical (animal, in vitro, computational): 44 of 692024, Reviews and meta-analyses: 13 of 692024, Other and not yet classified: 2 of 692025, Human clinical research: 10 of 792025, Preclinical (animal, in vitro, computational): 47 of 792025, Reviews and meta-analyses: 18 of 792025, Other and not yet classified: 4 of 792026 (to date), Human clinical research: 6 of 612026 (to date), Preclinical (animal, in vitro, computational): 35 of 612026 (to date), Reviews and meta-analyses: 17 of 612026 (to date), Other and not yet classified: 3 of 61Human clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classified010020030019891997200520132026*
Counted PubMed publications by year of first publication. * 2026 runs to November 8, 2026. A larger bar is more publications, not stronger evidence.
Show the data
YearHuman clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classifiedTotal
198901001
19900120113
19910261229
19922473254
19931712276
19941878197
1995310535116
199611532310187
1997312773140
19983173187201
1999111694130
2000116782178
2001213680146
20021135193158
20032106141123
20042106173128
200518510399
20066142166170
2007687303126
2008497143118
200937710090
20108110123133
201155915281
201257910195
201367216498
201478763103
201576611286
201614629287
201725111367
201836228194
201986019289
2020105218282
2021115725497
202285518485
2023116023195
2024104413269
2025104718479
2026 (to date)63517361

Study types

Animal study2,613
In vitro study487
Review484
Observational human study114
Editorial, letter or other59
Not yet classified45
Randomized controlled trial31
Other clinical trial26
Computational study14
Case report3
Systematic review3
Meta-analysis2

Research areas

From MeSH major topics. A paper can be in several areas.

Neurological and mental health1,899
Endocrinology827
Cardiovascular373
Immune system327
Gastrointestinal295
Reproductive and sexual health227
Oncology199
Metabolic health191
Tissue repair177
Musculoskeletal126
Cognitive health119
Longevity and aging56

Registered clinical trials

7 of 10 trials completed at least a year before the cutoff have neither posted results nor a linked results publication. A registration is not a result.

Completed: 10 · Unknown status: 2 · Not yet recruiting: 1
Phase not applicable: 12 · Phase 1: 1

TrialStatusPhaseStartedResults
Induction of Migraine Attacks With Aura Using Pituitary Adenylate Cyclase Activating Polypeptide-38NCT07342296 · 21 enrolledNot yet recruitingPhase not applicable2026-02—
Migraine Induction Properties of PACAP-38 After Eptinezumab in Migraine Without Aura Patients.NCT05635604 · 38 enrolledCompletedPhase not applicable2023-03—
Hypersensitivity to PACAP-38 in Post-Traumatic HeadacheNCT05378061 · 21 enrolledUnknown statusPhase not applicable2022-06—
The Hemodynamic Effects of PACAP38 After Glibenclamide Administration in Healthy VolunteersNCT04960657 · 22 enrolledCompletedPhase not applicable2020-10—
PACAP38 Induced Headache, Migraine and Flushing in Patients With MigraineNCT03881644 · 37 enrolledCompletedPhase not applicable2018-07—
The Effect of PACAP27 on the Extra- and Intracerebral Arteries Assessed by Magnetic Resonance Angiography (MRA) on Healthy VolunteersNCT03560024 · 18 enrolledCompletedPhase not applicable2018-05—
PACAP-38 Infusion in Patients With Cluster HeadacheNCT03814226 · 45 enrolledUnknown statusPhase not applicable2018-01—
PACAP27 Headache Properties in Migraine Without Aura PatientsNCT03471039 · 20 enrolledCompletedPhase not applicable2017-08—
To Evaluate the Blockade of CGRP in Preventing PACAP-38 Induced Migraine-like Attacks With AMG 334 in Migraine PatientsNCT02542605 · 35 enrolledCompletedPhase 12015-11Posted
The Effect of Histamine H1 Receptor Antagonist, Clemastin, on PACAP38 Induced Headache in Migraine PatientsNCT02364453 · 20 enrolledCompletedPhase not applicable2015-02—
PACAP Induced Migraine Attacks in Patients With High and Low Genetic LoadNCT02158221 · 32 enrolledCompletedPhase not applicable2014-06—
Effect of PACAP38/VIP on Migraineurs Measured by Magnetic ResonanceNCT01471990 · 24 enrolledCompletedPhase not applicable2011-05—
PACAP38´s (Pituitary Adenylate Cyclase-Activating Polypeptide) Headache Inducing Characteristics and Effects on the Cerebral Blood FlowNCT00380263 · 12 enrolledCompletedPhase not applicable2006-11—

Human trials and evidence reviews

Meta-analyses, systematic reviews and trials in people, newest first.

  1. Blood serum levels of PACAP and migraine onset: A systematic review and meta-analysis of observational studies.

    Headache · April 24, 2024 · Meta-analysis · cited 7 times

    PMID 38659322 · DOI 10.1111/head.14711 · Reviews and meta-analyses

  2. Meta-analysis of microarray-derived data from PACAP-deficient adrenal gland in vivo and PACAP-treated chromaffin cells identifies distinct classes of PACAP-regulated genes.

    Peptides · June 19, 2007 · Meta-analysis · cited 17 times · open access

    PMID 17651866 · DOI 10.1016/j.peptides.2007.06.013 · Reviews and meta-analyses

  3. Blood levels of PACAP in migraine: A systematic review.

    Cephalalgia : an international journal of headache · August 11, 2026 · Systematic review · cited 0 times · open access

    PMID 42578875 · DOI 10.1177/03331024261468031 · Reviews and meta-analyses

  4. Vascular responses to molecular migraine triggers: a systematic review of magnetic resonance angiography studies.

    The journal of headache and pain · August 11, 2025 · Systematic review · cited 3 times · open access

    PMID 40790620 · DOI 10.1186/s10194-025-02105-0 · Reviews and meta-analyses

  5. Genes involved in paediatric apnoea and death based on knockout animal models: Implications for sudden infant death syndrome (SIDS).

    Paediatric respiratory reviews · September 23, 2021 · Systematic review · cited 2 times

    PMID 34750067 · DOI 10.1016/j.prrv.2021.09.003 · Reviews and meta-analyses

  6. Preclinical and clinical evaluation of LY3451838, a PACAP-neutralizing monoclonal antibody, in randomized, double-blind, placebo-controlled phase 1 and phase 2 studies involving healthy adults and adults with treatment-resistant migraine.

    Cephalalgia : an international journal of headache · August 21, 2025 · Randomized controlled trial · cited 11 times · open access

    PMID 40836866 · DOI 10.1177/03331024251368757 · Human clinical research

  7. PACAP38-induced migraine attacks are independent of CGRP signaling: a randomized controlled trial.

    The journal of headache and pain · April 14, 2025 · Randomized controlled trial · cited 25 times · open access

    PMID 40229719 · DOI 10.1186/s10194-025-02022-2 · Human clinical research

  8. A Monoclonal Antibody to PACAP for Migraine Prevention.

    The New England journal of medicine · September 1, 2024 · Randomized controlled trial · cited 103 times

    PMID 39231342 · DOI 10.1056/nejmoa2314577 · Human clinical research

  9. Hypersensitivity to PACAP-38 in post-traumatic headache: a randomized clinical trial.

    Brain : a journal of neurology · April 1, 2024 · Randomized controlled trial · cited 26 times · open access

    PMID 37864847 · DOI 10.1093/brain/awad367 · Human clinical research

  10. Effects of Transcranial Direct Current Stimulation on Clinical Outcomes, Calcitonin Gene-Related Peptide, and Pituitary Adenylate Cyclase-Activating Polypeptide-38 Levels in Menstrual Migraine.

    Neuromodulation : journal of the International Neuromodulation Society · March 19, 2024 · Randomized controlled trial · cited 4 times

    PMID 38506767 · DOI 10.1016/j.neurom.2024.01.005 · Human clinical research

Most cited

By OpenAlex citation count. Citations measure attention, not quality or correctness.

  1. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells.

    Biochemical and biophysical research communications · October 1, 1989 · Animal study · cited 1,831 times

    PMID 2803320 · DOI 10.1016/0006-291x(89)91757-9 · Animal studies

  2. Molecular, spatial, and functional single-cell profiling of the hypothalamic preoptic region.

    Science (New York, N.Y.) · November 1, 2018 · Animal study · cited 1,357 times · open access

    PMID 30385464 · DOI 10.1126/science.aau5324 · Animal studies

  3. Differential signal transduction by five splice variants of the PACAP receptor.

    Nature · September 1, 1993 · Animal study · cited 1,182 times

    PMID 8396727 · DOI 10.1038/365170a0 · Animal studies

  4. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions.

    Pharmacological reviews · June 1, 2000 · Review · cited 1,121 times · open access

    PMID 10835102 · DOI 10.1016/s0031-6997(24)01449-2 · Reviews and meta-analyses

  5. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery.

    Pharmacological reviews · September 1, 2009 · Review · cited 1,059 times

    PMID 19805477 · DOI 10.1124/pr.109.001370 · Reviews and meta-analyses

Latest publications

  1. Regulation of PACAP gene expression by ovarian sex steroids and kisspeptin: Study using hypothalamic cell lines and an <i>in vivo</i> female rat model.

    Biochemistry and biophysics reports · October 17, 2026 · In vitro study · cited 0 times

    PMID 42936012 · DOI 10.1016/j.bbrep.2026.102834 · In vitro studies

  2. Acupuncture alleviates form-deprivation myopia by promoting dopamine secretion and suppressing ferroptosis, potentially involving the PACAP-AC/cAMP pathway.

    Histology and histopathology · September 24, 2026 · Animal study · cited 0 times

    PMID 42779258 · DOI 10.14670/hh-25-141 · Animal studies

  3. The relationship between inflammation and multiple myeloma: insights into alterations and prognostic value.

    GeroScience · September 12, 2026 · Observational human study · cited 0 times · open access

    PMID 42730912 · DOI 10.1007/s11357-026-02494-3 · Human clinical research

  4. PACAP neurons of the ventral dentate gyrus are not involved in fear acquisition.

    Physiology & behavior · September 10, 2026 · Animal study · cited 0 times

    PMID 42722221 · DOI 10.1016/j.physbeh.2026.115503 · Animal studies

  5. Substance P and PACAP activate dural mast cells through MRGPRX2, not NK1R or PAC<sub>1</sub>/VPAC receptors.

    Cephalalgia : an international journal of headache · August 21, 2026 · In vitro study · cited 0 times · open access

    PMID 42627518 · DOI 10.1177/03331024261480167 · In vitro studies

  6. PACAP-38 is increased in the tear fluid of patients with migraine.

    Journal of neurology, neurosurgery, and psychiatry · August 13, 2026 · Editorial, letter or other · cited 0 times

    PMID 41850768 · DOI 10.1136/jnnp-2025-337981 · Commentary and other

  7. Blood levels of PACAP in migraine: A systematic review.

    Cephalalgia : an international journal of headache · August 11, 2026 · Systematic review · cited 0 times · open access

    PMID 42578875 · DOI 10.1177/03331024261468031 · Reviews and meta-analyses

  8. Pharmacological Modulation of the Kynurenine Pathway Using PF-04859989 Modulates PACAP Signaling in Migraine-Relevant Trigeminal Sensitization.

    Biomolecules · August 3, 2026 · Animal study · cited 0 times · open access

    PMID 42650796 · DOI 10.3390/biom16081128 · Animal studies

  9. Pituitary adenylate cyclase-activating polypeptide and mitochondrial homeostasis in neuronal injury: mechanisms and translational prospects.

    Frontiers in immunology · August 3, 2026 · Review · cited 0 times · open access

    PMID 42614376 · DOI 10.3389/fimmu.2026.1893747 · Reviews and meta-analyses

  10. HIF-1α and HIF-2α Are Upregulated in the Hippocampus but Not in the Medial Prefrontal Cortex in Experimental PTSD.

    Brain and behavior · August 1, 2026 · Animal study · cited 0 times · open access

    PMID 42552943 · DOI 10.1002/brb3.71654 · Animal studies

Browse all 3,881 publications in the dashboard

How this is counted

PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology

Search terms: PACAP; PACAP38; Pituitary adenylate cyclase activating polypeptide; Pituitary adenylate cyclase-activating polypeptide-38

((TITLE_ABS:"PACAP" OR CHEM:"PACAP") OR (TITLE_ABS:"PACAP38" OR CHEM:"PACAP38" OR TITLE_ABS:"PACAP 38" OR CHEM:"PACAP 38") OR (TITLE_ABS:"Pituitary adenylate cyclase activating polypeptide" OR CHEM:"Pituitary adenylate cyclase activating polypeptide") OR (TITLE_ABS:"Pituitary adenylate cyclase-activating polypeptide-38" OR CHEM:"Pituitary adenylate cyclase-activating polypeptide-38" OR TITLE_ABS:"Pituitary adenylate cyclase-activating polypeptide38" OR CHEM:"Pituitary adenylate cyclase-activating polypeptide38")) AND SRC:MED

Cite this page

Peptide Library. (2026, November 9). PACAP-38 research statistics (Version weekly-2026-11-08) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/pacap-38